AU6332396A - Platelet-specific chimeric immunoglobulin and methods of use therefor - Google Patents
Platelet-specific chimeric immunoglobulin and methods of use thereforInfo
- Publication number
- AU6332396A AU6332396A AU63323/96A AU6332396A AU6332396A AU 6332396 A AU6332396 A AU 6332396A AU 63323/96 A AU63323/96 A AU 63323/96A AU 6332396 A AU6332396 A AU 6332396A AU 6332396 A AU6332396 A AU 6332396A
- Authority
- AU
- Australia
- Prior art keywords
- platelet
- methods
- specific chimeric
- chimeric immunoglobulin
- use therefor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US475526 | 1990-02-06 | ||
US47552695A | 1995-06-07 | 1995-06-07 | |
PCT/US1996/010216 WO1996040250A2 (en) | 1995-06-07 | 1996-06-05 | Platelet-specific chimeric immunoglobulin and methods of use therefor |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU58388/99A Division AU5838899A (en) | 1995-06-07 | 1999-11-09 | Platelet-specific chimeric immunoglobulin and methods of use therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6332396A true AU6332396A (en) | 1996-12-30 |
Family
ID=23887963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU63323/96A Abandoned AU6332396A (en) | 1995-06-07 | 1996-06-05 | Platelet-specific chimeric immunoglobulin and methods of use therefor |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0835135A2 (en) |
JP (1) | JPH11511120A (en) |
CN (1) | CN1186439A (en) |
AU (1) | AU6332396A (en) |
CA (1) | CA2223885A1 (en) |
NZ (1) | NZ513882A (en) |
WO (1) | WO1996040250A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6590079B2 (en) | 1997-01-30 | 2003-07-08 | Ixsys, Incorporated | Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same |
US6596850B1 (en) | 1998-01-30 | 2003-07-22 | Ixsys, Incorporated | Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same |
AU768295B2 (en) * | 1998-11-03 | 2003-12-04 | Centocor Inc. | Modified antibodies and antibody fragments with increased duration of activity |
AUPP783198A0 (en) * | 1998-12-21 | 1999-01-21 | Resmed Limited | Determination of mask fitting pressure and correct mask fit |
EP1174148A4 (en) * | 1999-04-28 | 2005-05-04 | Yamanouchi Pharma Co Ltd | Parenteral medicinal composition containing humanized monoclonal antibody fragment and method for stabilizing the same |
US6531580B1 (en) | 1999-06-24 | 2003-03-11 | Ixsys, Inc. | Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same |
JP4910695B2 (en) * | 2004-02-25 | 2012-04-04 | アステラス製薬株式会社 | Thrombus contrast agent |
EP2789631A1 (en) * | 2013-04-10 | 2014-10-15 | Synapse B.V. | Compounds and methods for inhibition of binding of ICAM-4 to platelet integrin alphaIIbbeta3 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5318899A (en) * | 1989-06-16 | 1994-06-07 | Cor Therapeutics, Inc. | Platelet aggregation inhibitors |
DE69224983T2 (en) * | 1991-01-17 | 1998-07-30 | Univ Washington | ANTI-GROWTH FACTOR ANTIBODIES IN THE TREATMENT OF Vascular Stenosis |
JPH09504795A (en) * | 1993-11-05 | 1997-05-13 | セントコール,インコーポレイテッド | Platelet-specific chimeric immunoglobulin and method of using the same |
-
1996
- 1996-06-05 EP EP96922452A patent/EP0835135A2/en not_active Withdrawn
- 1996-06-05 NZ NZ513882A patent/NZ513882A/en not_active Application Discontinuation
- 1996-06-05 CA CA002223885A patent/CA2223885A1/en not_active Abandoned
- 1996-06-05 CN CN96194312A patent/CN1186439A/en active Pending
- 1996-06-05 AU AU63323/96A patent/AU6332396A/en not_active Abandoned
- 1996-06-05 JP JP9502244A patent/JPH11511120A/en active Pending
- 1996-06-05 WO PCT/US1996/010216 patent/WO1996040250A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ513882A (en) | 2001-09-28 |
CN1186439A (en) | 1998-07-01 |
EP0835135A2 (en) | 1998-04-15 |
WO1996040250A2 (en) | 1996-12-19 |
CA2223885A1 (en) | 1996-12-19 |
WO1996040250A3 (en) | 1997-01-23 |
JPH11511120A (en) | 1999-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6011096A (en) | Chimeric leptin fused to immunoglobulin domain and use | |
AU5155398A (en) | Anti-ccr5 antibodies and methods of use therefor | |
AU1087497A (en) | Clamp assembly and method of use | |
AU1209495A (en) | Human monoclonal antibodies against human cytokines and methods of making and using such antibodies | |
AU4617696A (en) | Transformer and method of assembly | |
AU7435296A (en) | Novel expression vectors and methods of use | |
AU5422696A (en) | Nox catalyst and method of using the same | |
SG48420A1 (en) | Humanized antibodies and uses thereof | |
AU1023797A (en) | Reduction of hair growth | |
AU5178196A (en) | Reduction of hair growth | |
AU4653996A (en) | Logarithm/inverse-logarithm converter and method of using same | |
AU7422496A (en) | NM03 antibody materials and methods | |
AU7621496A (en) | Microsensor and use of such microsensor | |
AU5880996A (en) | Container and closure assembly and method of making same | |
AU6750594A (en) | Receptors of interleukin-12 and antibodies | |
AU4013495A (en) | Chemokine-like proteins and methods of use | |
AU7326796A (en) | Stable chicken b-cell line and method of use thereof | |
AU6332396A (en) | Platelet-specific chimeric immunoglobulin and methods of use therefor | |
AU4224096A (en) | Use of phenylcyclohexylcarboxamides | |
AU5667896A (en) | Tar-depleted liquid smoke and method of manufacture | |
AU6282696A (en) | Functional surrogates of analytes of interest and methods of obtaining and using same | |
AU5180296A (en) | Container and method of making same | |
AU3342093A (en) | Lens and method of making same | |
AU6667196A (en) | Determination of chromium | |
AU5647894A (en) | Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |